"L’hôpital de la Citadelle (Liège) est l’un des plus grands hôpitaux francophones de Belgique : plus de 600 médecins, une trentaine de spécialités, 4.100 collaborateurs, 900 lits, 3 sites hospitaliers (Citadelle, Laveu, Herstal), une quarantaine de centres de prélèvements LaboCita répartis dans la province de Liège… « L’excellence, à vos côtés » est un mantra partagé par l’ensemble du personnel et qui peut se décliner en trois valeurs-clés : excellence, humanité, proximité"

During the past decade, Chr de La Citadelle conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 41 clinical trials were completed, i.e. on average, 36.6% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 26 clinical trials were completed. i.e. 54.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chr de La Citadelle" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Boehringer Ingelheim" with 7 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Amgen" with 6 trials sponsored. Other sponsors include 150 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chr de La Citadelle" #1 collaborator was "Centre Hospitalier Régional de la Citadelle" with 5 trials as a collaborator, "Centre Hospitalier Universitaire de Liege" with 5 trials as a collaborator, "Sysnav" with 4 trials as a collaborator, "Amgen" with 3 trials as a collaborator and "Belgium Health Care Knowledge Centre" with 3 trials as a collaborator. Other collaborators include 203 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "Chr de La Citadelle" are "Breast Cancer" (7 trials), "Heart Failure" (7 trials), "Atrial Fibrillation" (5 trials), "Duchenne Muscular Dystrophy" (5 trials) and "Muscular Atrophy, Spinal" (5 trials). Many other conditions were trialed in "Chr de La Citadelle" in a lesser frequency.

Most popular intervention types in "Chr de La Citadelle" are "Drug" (124 trials), "Device" (23 trials), "Other" (23 trials), "Procedure" (19 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Paclitaxel" (4 trials), "Risdiplam" (4 trials), "Rituximab" (4 trials) and "laboratory biomarker analysis" (4 trials). Other intervention names were less common.

The vast majority of trials in "Chr de La Citadelle" are 162 trials for "All" genders, 26 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 59 active trials in "Chr de La Citadelle". 1 are not yet recruiting, 32 are recruiting, 23 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 106 completed trials in Chr de La Citadelle, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Chr de La Citadelle, 3 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 84 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 27 trials that are defined as “Not Applicable".

Chr de La Citadelle has several departments that took part in Clinical trials: "Centre de référence neuromusculaire, CHR La Citadelle" - 2 trials, "CHR de la Citadelle - Department of Gynaecology & Obstetrics" - 2 trials, "Hospital de La Citadelle, Centre de Référence des Maladies Neuromuscolaires (CRMN)" - 2 trials